IP Library Granted Patent US 12,194,141
Granted Patent B2
US 12,194,141 · App. 17/142,744 · Granted Jan 14, 2025

Succinylcholine prefilled syringe, compositions and methods

Inventors: Kumaresh Soppimath (Skillman, NJ); Tushar Hingorani (Bridgewater, NJ); Anant Patel (Pompton Lakes, NJ)
Assignee: NEVAKAR INJECTABLES INC.
A61K9/0019A61K31/137A61K31/225A61K47/02A61K47/12A61M5/1452A61M5/178A61M5/3129A61M25/0097A61M39/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,194,141
App. No.
17/142,744
Granted
Jan 14, 2025
Kind
B2
Abstract

Pre-filled syringes, pharmaceutical compositions, and kits and methods relating to same allow for emergency administration of one or more drugs from prefilled glass syringes to a patient via a needleless connector. In preferred embodiments, the prefilled glass syringe has a drug volume of at least 5 mL, has a Luer-lock, and has a syringe tip with an internal channel that has a diameter of about 1.7 mm. Such syringes advantageously allow storage of emergency drugs without leaching of plastic materials and degradation, and substantially improve the safety profile where the syringe is attached to an IV line via a needleless connector.

Claims (30)

1. A prefilled syringe, comprising:

a syringe barrel containing a ready-to-administer medication, wherein the barrel is fluidly coupled to a syringe tip;

a luer-lock coupled to the syringe to allow reversible attachment of the syringe to a needleless connector having a reversed internal blunt cannula;

wherein the luer-lock comprises a luer collar that is rotatable about the syringe tip;

a tip cap rotatably coupled to and removable from the luer collar; and

a polymeric band coupled to the syringe to prevent rotation of the luer collar about the syringe tip when the tip cap is removed from the luer collar,

wherein the medication is a succinylcholine composition, and

wherein the succinylcholine composition, when disposed in a glass syringe, contains not more than about 6% total impurities after storage at 2-8° C. for 15 months, followed by storage at about 25° C. for 14 days as determined by high performance liquid chromatography.

2. The prefilled syringe of claim 1 wherein the polymeric band directly couples the syringe barrel to the luer collar.

3. The prefilled syringe of claim 1 wherein the polymeric band indirectly couples the syringe barrel to the luer collar via a restraint ring.

4. The prefilled syringe of claim 3 wherein the restraint ring comprises a first and a second portion that can be moved relative to each other.

5. The prefilled syringe of claim 1 wherein the polymeric band comprises a shrink wrap polymer.

6. The prefilled syringe of claim 1 wherein the polymeric band comprises an adhesive.

7. The prefilled syringe of claim 1 wherein the syringe is a glass syringe.

8. The prefilled syringe of claim 1 wherein the syringe tip has in internal channel having a diameter of between 1.2-2.2 mm.

9. The prefilled syringe of claim 1 wherein the syringe tip has in internal channel having a diameter of at least 1.5 mm.

10. The prefilled syringe of claim 1 wherein the syringe tip has in internal channel having a diameter of about 1.7 mm.

11. The prefilled syringe of claim 1 , wherein the succinylcholine composition has a pH of about 3.0 to about 4.5.

12. A prefilled glass syringe, comprising:

a glass syringe having a barrel containing a ready-to-administer medication, wherein the barrel is fluidly coupled to a syringe tip;

a luer-lock coupled to the syringe to allow reversible attachment of the syringe to a needleless connector having a reversed internal blunt cannula;

wherein the luer-lock comprises a luer collar that is rotatable about the syringe tip;

a tip cap rotatably coupled to and removable from the luer collar;

a polymeric band coupled to the syringe to prevent rotation of the luer collar about the syringe tip when the tip cap is removed for the luer collar;

wherein the syringe tip has an internal channel that has a diameter of 1.2-2.2 mm inner diameter;

wherein the diameter of the internal channel and/or a length of the syringe tip is configured such that the syringe tip can be inserted into the needleless connector at an angle with respect to a hypothetical central axis extending through the barrel and the tip of the syringe and a hypothetical central axis longitudinally extending through the needleless connector without the reversed internal blunt cannula contacting the inner surface of the tip;

wherein the medication is a succinylcholine composition; and

wherein the succinylcholine composition disposed in the glass syringe contains not more than about 6% total impurities after storage at 2-8° C. for 12 months, followed by storage at about 25° C. for 14 days as determined by high performance liquid chromatography.

13. The prefilled glass syringe of claim 12 wherein the internal channel has a diameter of about 1.7 mm, and wherein the prefilled glass syringe contains 5 mL or 10 mL of the succinylcholine composition.

14. The prefilled glass syringe of claim 12 , wherein the succinylcholine composition has a pH between 3-4.

Assignments (4)
SECURITY INTEREST Recorded May 9, 2023
From: NEVAKAR INJECTABLES INC.
To: NOVAQUEST CO-INVESTMENT FUND IX, L.P.
Reel/Frame 063583/0948 →
PATENT SECURITY AGREEMENT Recorded May 4, 2023
From: NEVAKAR INJECTABLES INC.
To: H.I.G. BIO - NEVAKAR, L.P.
Reel/Frame 063545/0646 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2021
From: NEVAKAR INC.
To: NEVAKAR INJECTABLES INC.
Reel/Frame 057183/0825 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2021
From: SOPPIMATH, KUMARESH; AKASAPU, PREM SAGAR; HINGORANI, TUSHAR; PATEL, ANANT
To: NEVAKAR INC.
Reel/Frame 055039/0623 →
Continuity (5)
Continuation In Part 16909340 · Jun 23, 2020
Division 16836152 · Mar 31, 2020
Division 16272815 · Feb 11, 2019
Provisional Application 62642326 · Mar 13, 2018
Related Publication 20210121395A1 · Apr 29, 2021
References Cited (20)
US 9205243B2 · Lopez et al. · 2015 [cited by applicant]
US 9750926B2 · Lopez et al. · 2017 [cited by applicant]
US 20110130717A1 · David · 2011 [cited by examiner]
US 20120029438A1 · Vernizeau · 2012 [cited by examiner]
US 20130338602A1 · Thorley et al. · 2013 [cited by applicant]
US 20160022912A1 · Hernandez · 2016 [cited by applicant]
US 20160136352A1 · Smith · 2016 [cited by examiner]
US 20180099137A1 · Fangrow · 2018 [cited by applicant]
US 20190001114A1 · Fangrow · 2019 [cited by applicant]
US 20190201630A1 · Vogt · 2019 [cited by applicant]
WO 2017220553A1 · 2017 [cited by applicant]
Hospira, Inc. “Quelicin, Succinylcholine Chloride Injection, USP” Sep. 2010; 9 pgs (Year: 2010). [cited by examiner]
“FDA Drug Safety Communication: Connection problems involving certain needleless pre-filled glass syringes containing adenosine and amiodarone,” Drug Safety and Availability, May 6, 2011; 5 pgs. Retrieved from https://w… [cited by applicant]
“One-Link Needle-free IV Connector,” Sales Brochure, Baxter Healthcare Corporation, Nov. 2013; 6 pgs. [cited by applicant]
Ethiopian Food, Medicine and Health Care Administration and Control Authority, “Emergency Medicines List (EML), First Edition,” Nov. 2014, Addis Ababa; 41 pgs. [cited by applicant]
Excerpt from US FDA Jan. to Jun. 2019 outsourcing facility product report; 1 pg. [cited by applicant]
Excerpt from US FDA Jul. to Dec. 2018 outsourcing facility product report; 1 pg. [cited by applicant]
Hadaway, Lynn, MEd, RNC, CRNI, “Needleless Connectors for IV Catheters,” AJN, Nov. 2012, 112(11):32-44. [cited by applicant]
Hospira, Inc. “Quelicin, Succinylcholine Chloride Injection, USP” Sep. 2010; 9 pgs. [cited by applicant]
Intermountain Healthcare, “Giving Medication: IV Push” 2014, 2 pgs. [cited by applicant]